Bleakley Financial Group’s Insulet PODD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
– Sell
-1,565
Closed -$409K – 859
2024
Q4
$409K Buy
1,565
+65
+4% +$16.4K 0.01% 673
2024
Q3
$349K Buy
1,500
+17
+1% +$3.49K 0.01% 715
2024
Q2
$299K Buy
+1,483
New +$267K 0.01% 749
2024
Q1
– Sell
-1,112
Closed -$241K – 1019
2023
Q4
$241K Buy
+1,112
New +$191K 0.01% 798
2023
Q3
– Sell
-924
Closed -$266K – 938
2023
Q2
$266K Sell
924
-32
-3% -$9.72K 0.01% 759
2023
Q1
$305K Buy
956
+96
+11% +$28.5K 0.01% 705
2022
Q4
$253K Buy
+860
New +$237K 0.01% 739

Other funds holding PODD

Bleakley Financial Group's PODD Position: Q1 2025 in Review

Bleakley Financial Group sold out of Insulet (PODD) in Q1 2025, closing a stake of 1,565 shares — an estimated $409K sold.

Bleakley Financial Group first reported a position in PODD in Q4 2022 and held it in 7 quarters. The position peaked at $409K in Q4 2024. 719 funds tracked by Wall St. Rank hold PODD as of Q1 2025.

  • Bleakley Financial Group reported no remaining Insulet position as of Q1 2025 after selling out during the quarter.
  • Bleakley Financial Group sold 1,565 Insulet shares in Q1 2025, an estimated $409K.
  • Bleakley Financial Group first reported a position in Insulet in Q4 2022 and held it in 7 quarters.
  • Bleakley Financial Group's Insulet position peaked at $409K in Q4 2024.
  • 719 funds tracked by Wall St. Rank held Insulet as of Q1 2025.

Based on Bleakley Financial Group's 13F filing for Q1 2025, filed 1 May 2025.